Program
The final program for the workshop is currently being developed. The Preliminary program and program-at-a-glance are now available to the right of the screen in pdf format.
A number of renowned speakers have been invited to present at the workshop. Once they have confirmed their participation, their names and presentation titles will be added to this page. Please stay posted for updates.
Confirmed speakers:
-
D. Bangsberg: Antiretroviral treatment adherence: acute and chronic
David Bangsberg, MD is an Associate Professor in the Partner AIDS Research Center at Massachusetts General Hospital with appointments in the Harvard School of Medicine. He completed medical school at Johns Hopkins Hospital in Baltimore, his internal medicine residency at Columbia Presbyterian Hospital in ...
Read more
-
C. Benson: AIDS Clinical Trails Group
Constance Benson, M.D. is a Professor of Medicine, Senior Attending Physician, and the Infectious Disease Fellowship Training Program Director in the Department of Medicine/Division of Infectious Diseases at the University of California, San Diego School of Medicine. She is also the Principal Investigator and Chair of the Executive Committee and Vice Chair of the ...
Read more
-
C. Boucher: Drug Resistance
Charles A. B. Boucher, MD, PhD, is Professor in the Department of Virology Erasmus Medical Center, Erasmus University Rotterdam, The Netherlands. Dr Boucher received his medical degree cum laude from the Faculty of Medicine of the University of Amsterdam, The Netherlands. Specializing in medical microbiology, he also received a PhD degree ...
Read more
-
N. Chintu: Pediatric HIV infection: State-of-the-Art
Namwinga Chintu MD is the Deputy Director of the Centre for Infectious Disease Research in Zambia (CIDRZ). She received her medical degree from the University of Zambia and later specialized in Pediatrics and Child Health. She also trained in Tropical Pediatrics at the University of Liverpool. She holds an honorary lecturer position at in the University Teaching Hospital Department of Pediatrics and an ...
Read more
-
R. Koup: HIV vaccines
Richard Koup MD is a Senior Investigator and Chief of the Immunology Laboratory at the Vaccine Research Center (VRC) within the National Institute of Allergy and Infectious Diseases in Bethesda, Maryland. Dr. Koup has spent most of his career studying the protective role of HIV-specific cellular immunity. His specific research involves the characterization of T cells factors that are involved in the ...
Read more
-
M. Lederman: HIV immunology update
Michael Lederman MD is the Scott R. Inkley Professor of Medicine at Case Western Reserve University School of Medicine and University Hospitals of Cleveland where he is also Professor of Biomedical Ethics, Pathology, Microbiology and Molecular Biology. Dr. Lederman received his bachelor’s degree in Biology from Brandeis ...
Read more
-
T. Mastro: HIV-incidence determination: state-of-the-art
Dr. Timothy Mastro MD, FACP, DTM&H is Vice President for Health and Development Sciences at Family Health International (FHI), Research Triangle Park, North Carolina, USA. He is also Adjunct Professor of Epidemiology in the Gillings School of Global Public Health, University of North Carolina at Chapel Hill. Dr. Mastro joined FHI in 2008 following 20 years at the US Centers for Disease ...
Read more
-
H. Rees: ’’Combination HIV-prevention: putting different prevention modalities in context
Helen Rees MD is the Executive Director of the Reproductive Health and HIV Research Unit (RHRU), the largest research unit of the University of the Witwatersrand, Johannesburg, where she is also an Associate Professor in the Department of Obstetrics and Gynaecology. Prof Rees received her Medical Degree and her Masters in Social and Political Sciences from Cambridge ...
Read more
-
P. Reiss: HAART, drug toxicities, non-AIDS morbidity and aging
Peter Reiss, MD, PhD, is Associate Professor of Medicine at the Academic Medical Center (AMC), University of Amsterdam, the Netherlands. He also serves as Deputy Director of the Dutch National AIDS Therapy Evaluation Center ( NATEC ), which is supported by the Dutch government to coördinate HIV/AIDS clinical trials in the Netherlands. In addition he acts as Scientic Adviser ...
Read more
-
P.Salif Sow
1 New WHO treatment guidelines & 2 African Network for AIDS Physians: ANEPA’’ (with Prof. Serge Eholié) Papa Salif Sow MD, MS is a Professor of Infectious Diseases at the University of Dakar in Senegal. He received his Medical Degree from the faculty of medicine of the University of Dakar in 1987. He trained as a physician specialized in ...
Read more
-
E. Sanders: Concentrated HIV epidemics: focus on MSM
Eduard Sanders, MD, MPH, PhD. Dr. Sanders is an epidemiologist affiliated with Oxford University and supported by the International AIDS Vaccine Initiative (IAVI). He initiated the establishment of the District Hospital HIV care and research programme in Kilifi in 2003 and is the principal investigator for the high risk open-cohort study, ...
Read more
-
R. Schooley: ART for HIV prevention
Robert Schooley MD is a graduate of the Johns Hopkins University School of Medicine. After internal medicine training at the Johns Hopkins Hospital, he completed Clinical and Research Fellowships at the National Institute of Allergy and Infectious Diseases and at the Massachusetts General Hospital. He joined the faculty of Harvard Medical School in 1981 where he rose to the ...
Read more
-
J. van de Wijgert: Microbicides: State-of-the-Art
Janneke Janneke van de Wijgert, PhD, is a senior epidemiologist at IATEC Foundation and the Center for Poverty-related Communicable Diseases (CPCD) at the AMC, University of Amsterdam. She is/was Principal or co-investigator on several safety and effectiveness trials of vaginal microbicides for HIV prevention, as well as other ...
Read more
.
Prof. Jan Francois Delfraissy, National Agency for Aids Research (ANRS), France
"Agence National de Recherches sur le Sida et les hepatites virales"
Dr. Guido Ferrari, Duke University Medical Center, Durham
"The use of flow cytometry in resource-poor settings"
Prof. James Hakim, AIDS/HIV Ambassador of the Netherlands
"Co-infections (excl. HIV/TB)"
Dr. Andrew Kambugu, Infectious Diseases Institute, Mulago Hospital, Kampala
"Role of new drugs"
Dr. John Kinuthia, Kenyatta National Hospital, University of Nairobi, Kenya
"PMPCT"
Prof. Emilia Noormahomed, Universidade Eduardo Mondlane, School of Medicine, Mozambique
"HIV research in Mozambique"
Dr. Thomas Nyirenda, EDCTP, South Africa
"European & Developing Countries Clinical Trails Partnership"
Dr. Lynn Paxton, Centers for Disease Control and Prevention, USA
1. "PREP"
2. "Centers for Disease Control and Prevention"
Dr. Michel Sidibe, UNAIDS, Geneva, Switzerland
“Global HIV epidemiology in 2010 and beyond”
Prof. Serge Eholié, Dr. Treichville Hospital, Ivory Coast
1. "Third line regimens: what are the options?"
2. “African Network for AIDS Physicians: ANEPA’’ (with Prof. Papa Salif Sow)
Dr. Francois Venter, HIV Management Cluster, University of the Witwatersrand, South Africa
"Pros and cons of various second line regimens"
Prof. Robin Wood, University of Cape Town Faculty of Health, South Africa
“HIV TB co-infections”
